A separator for separating raw milk into a skimmed milk phase, a cream phase and an ejection phase that comprises solid impurities is disclosed. The separator includes an ejection port arranged at a periphery of the separator to eject the ejection phase. A cyclone is connected to the ejection port to receive and decelerate the ejection phase, and a vessel in fluid communication with an ejection phase outlet of the cyclone to receive and collect the ejection phase from the cyclone. The cyclone includes a port that is open to the atmosphere, such that pressure build-up created in the cyclone when the ejection phase is ejected from the separator into the cyclone is released.

The present invention relates to a process for the production of a dairy composition from a starting material containing lactose. The present invention also relates to the compositions produced by the process of the invention as well as the foods and drinks containing the compositions.

Disclosed is a method of inhibiting isomerization of a reducing saccharide in an aqueous solution containing said reducing saccharide upon thermal treatment of said aqueous saccharide solution by acidifying the aqueous saccharide solution prior to its thermal treatment, and the use of the thermally treated aqueous solution containing said reducing saccharide for producing a biological product.

A device and a method are for sterilization of milk from livestock such as cows, sheep or goats. The milk, prior to an irradiation with UV-C light through a light translucent barrier, is homogenized since the milk is exposed to ultrasound. The milk simultaneously to or after the homogenization is exposed to an electrical field, such as a field with changing polarity, where polarity change and field strength are chosen such that the milk in the electrical field is heated due to the milk's resistance.

A device and a method are for sterilization of milk from livestock such as cows, sheep or goats. The milk, prior to an irradiation with UV-C light through a light translucent barrier, is homogenized since the milk is exposed to ultrasound. The milk simultaneously to or after the homogenization is exposed to an electrical field, such as a field with changing polarity, where polarity change and field strength are chosen such that the milk in the electrical field is heated due to the milk's resistance.

A method for the inactivation and inactivation testing of xenoantigens in foods of vegetable and animal origin, comprising the following steps: making up a solution with a food of vegetable or animal origin as a solvent and one or more phenolic compounds, polyphenolic compounds and derivatives thereof, comprising phenylpropanoids, as a solute, for the inactivation of at least part of the xenogeneic epitopes from said food, incubating samples of the food of vegetable or animal origin with the addition of an antibody aimed at a xenoantigen epitope that is present in the food, separating the resulting immune complex created owing to the bond between antigen and antibody, preparing a well plate for the E.L.I.S.A. test with coating with xenoantigen epitope, adding, in the wells, supernatant taken from the samples, the supernatant containing the part of antibody that has not bonded with epitopes, a column of wells being adapted to define a reference value that corresponds to the maximum signal between antibody and epitopes, completing the plate with a secondary antibody conjugated with an enzyme, or other molecule, adapted to chromatically highlight any presence of anti-xenoantigen antibody, reading the plate, determining the presence of anti-xenoantigen antibody that has remained free in the solutions of the samples, comparing the absorbance values detected in the reference column with the values in the other columns of samples of the plate.

A method for the inactivation and inactivation testing of xenoantigens in foods of vegetable and animal origin, comprising the following steps: making up a solution with a food of vegetable or animal origin as a solvent and one or more phenolic compounds, polyphenolic compounds and derivatives thereof, comprising phenylpropanoids, as a solute, for the inactivation of at least part of the xenogeneic epitopes from said food, incubating samples of the food of vegetable or animal origin with the addition of an antibody aimed at a xenoantigen epitope that is present in the food, separating the resulting immune complex created owing to the bond between antigen and antibody, preparing a well plate for the E.L.I.S.A. test with coating with xenoantigen epitope, adding, in the wells, supernatant taken from the samples, the supernatant containing the part of antibody that has not bonded with epitopes, a column of wells being adapted to define a reference value that corresponds to the maximum signal between antibody and epitopes, completing the plate with a secondary antibody conjugated with an enzyme, or other molecule, adapted to chromatically highlight any presence of anti-xenoantigen antibody, reading the plate, determining the presence of anti-xenoantigen antibody that has remained free in the solutions of the samples, comparing the absorbance values detected in the reference column with the values in the other columns of samples of the plate.

Provided are compositions and methods for treating, ameliorating and preventing various infections, disorders and conditions in mammals, including genetically-predisposed and chronic disorders, where a microbial or bacterial flora is at least one causative or symptom-producing factor, where exemplary compositions are products of manufacture, a food, a drink, a nutraceutical, a dietary supplement, a formulation, a pharmaceutical or a pharmaceutical preparation comprising at least one or several of: a plurality of isolated, or substantially purified bacteriophages or prophages, or bacteriophage subunits, a milk, a milk product, milk lipid, milk fat globule (MFG) macromolecule, a milk mucin, a milk glycolipid, a milk free glycan, a milk mucin-like glycoprotein, a milk protein, a milk sugar or lactose, a milk fat or butterfat, a milk vitamin. In alternative embodiment, provided are compositions and methods for treating, preventing or ameliorating an infection, for example, an infection in the gastrointestinal tract, or bowel.

Provided are compositions and methods for treating, ameliorating and preventing various infections, disorders and conditions in mammals, including genetically-predisposed and chronic disorders, where a microbial or bacterial flora is at least one causative or symptom-producing factor, where exemplary compositions are products of manufacture, a food, a drink, a nutraceutical, a dietary supplement, a formulation, a pharmaceutical or a pharmaceutical preparation comprising at least one or several of: a plurality of isolated, or substantially purified bacteriophages or prophages, or bacteriophage subunits, a milk, a milk product, milk lipid, milk fat globule (MFG) macromolecule, a milk mucin, a milk glycolipid, a milk free glycan, a milk mucin-like glycoprotein, a milk protein, a milk sugar or lactose, a milk fat or butterfat, a milk vitamin. In alternative embodiment, provided are compositions and methods for treating, preventing or ameliorating an infection, for example, an infection in the gastrointestinal tract, or bowel.

A separator for separating raw milk into a skimmed milk phase, a cream phase and an ejection phase that comprises solid impurities is disclosed. The separator includes an ejection port arranged at a periphery of the separator to eject the ejection phase. A cyclone is connected to the ejection port to receive and decelerate the ejection phase, and a vessel in fluid communication with an ejection phase outlet of the cyclone to receive and collect the ejection phase from the cyclone. The cyclone includes a port that is open to the atmosphere, such that pressure build-up created in the cyclone when the ejection phase is ejected from the separator into the cyclone is released.